{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:36:54Z","timestamp":1791113814932,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T00:00:00Z","timestamp":1318550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T00:00:00Z","timestamp":1318550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/cdd.2011.133","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T05:07:13Z","timestamp":1318568833000},"page":"623-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacological blockade of Bcl-2, Bcl-xL and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice"],"prefix":"10.1038","volume":"19","author":[{"given":"S","family":"Grabow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Happo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K D","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P N","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,14]]},"reference":[{"key":"BFcdd2011133_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava S, Zou ZQ, Pirollo K, Plattner W, Chang EH . Germline transmission of a mutated p53 gene in a cancer-prone family with Li\u2013Fraumeni syndrome. Nature 1990; 348: 747\u2013749.","journal-title":"Nature"},{"key":"BFcdd2011133_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JFJ, Nelson CE, Kim DH et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233\u20131238.","journal-title":"Science"},{"key":"BFcdd2011133_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS et al. Mice deficient for p53 are developmentally normal but are susceptible to spontaneous tumours. Nature 1992; 356: 215\u2013221.","journal-title":"Nature"},{"key":"BFcdd2011133_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4: 1\u20137.","journal-title":"Curr Biol"},{"key":"BFcdd2011133_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","volume":"119","author":"KP Olive","year":"2004","unstructured":"Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT et al. Mutant p53 gain of function in two mouse models of Li\u2013Fraumeni syndrome. Cell 2004; 119: 847\u2013860.","journal-title":"Cell"},{"key":"BFcdd2011133_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP . p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275\u2013283.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcdd2011133_CR7","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJMra0901217","volume":"361","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss RS, Strasser A, McDunn JE, Swanson PE . Cell death. N Engl J Med 2009; 361: 1570\u20131583.","journal-title":"N Engl J Med"},{"key":"BFcdd2011133_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA . The hallmarks of cancer. Cell 2000; 100: 57\u201370.","journal-title":"Cell"},{"key":"BFcdd2011133_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A . The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcdd2011133_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR Green","year":"2004","unstructured":"Green DR, Kroemer G . The pathophysiology of mitochondrial cell death. Science 2004; 305: 626\u2013629.","journal-title":"Science"},{"key":"BFcdd2011133_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","volume":"103","author":"DCS Huang","year":"2000","unstructured":"Huang DCS, Strasser A . BH3-only proteins \u2013 essential initiators of apoptotic cell death. Cell 2000; 103: 839\u2013842.","journal-title":"Cell"},{"key":"BFcdd2011133_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nrd2658","volume":"7","author":"G Lessene","year":"2008","unstructured":"Lessene G, Czabotar PE, Colman PM . BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov 2008; 7: 989\u20131000.","journal-title":"Nat Rev Drug Discov"},{"key":"BFcdd2011133_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"T Oltersdorf","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435: 677\u2013681.","journal-title":"Nature"},{"key":"BFcdd2011133_CR14","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.1021\/jm800669s","volume":"51","author":"CM Park","year":"2008","unstructured":"Park CM, Bruncko M, Adickes J, Bauch J, Ding H, Kunzer A et al. Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. J Med Chem 2008; 51: 6902\u20136915.","journal-title":"J Med Chem"},{"key":"BFcdd2011133_CR15","doi-asserted-by":"publisher","first-page":"17961","DOI":"10.1073\/pnas.0809957105","volume":"105","author":"KD Mason","year":"2008","unstructured":"Mason KD, Vandenberg CJ, Scott CL, Wei AH, Cory S, Huang DC et al. In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proc Natl Acad Sci USA 2008; 105: 17961\u201317966.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2011133_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc2615","volume":"9","author":"MS Cragg","year":"2009","unstructured":"Cragg MS, Harris C, Strasser A, Scott CL . Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer 2009; 9: 321\u2013326.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd2011133_CR17","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","volume":"22","author":"S Cory","year":"2003","unstructured":"Cory S, Huang DC, Adams JM . The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590\u20138607.","journal-title":"Oncogene"},{"key":"BFcdd2011133_CR18","first-page":"427","volume":"12","author":"HS Kaplan","year":"1951","unstructured":"Kaplan HS, Brown MB . Further observations on inhibition of lymphoid tumor development by shielding and partial-body irradiation of mice. J Natl Cancer Inst 1951; 12: 427\u2013436.","journal-title":"J Natl Cancer Inst"},{"key":"BFcdd2011133_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ng0994-66","volume":"8","author":"CJ Kemp","year":"1994","unstructured":"Kemp CJ, Wheldon T, Balmain A . p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994; 8: 66\u201369.","journal-title":"Nat Genet"},{"key":"BFcdd2011133_CR20","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.1940110","volume":"24","author":"EM Michalak","year":"2010","unstructured":"Michalak EM, Vandenberg CJ, Delbridge ARD, Wu L, Scott CL, Adams JM et al. Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 2010; 24: 1608\u20131613.","journal-title":"Genes Dev"},{"key":"BFcdd2011133_CR21","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1101\/gad.1940210","volume":"24","author":"V Labi","year":"2010","unstructured":"Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev 2010; 24: 1602\u20131607.","journal-title":"Genes Dev"},{"key":"BFcdd2011133_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0092-8674(94)90201-1","volume":"79","author":"A Strasser","year":"1994","unstructured":"Strasser A, Harris AW, Jacks T, Cory S . DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994; 79: 329\u2013339.","journal-title":"Cell"},{"key":"BFcdd2011133_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/0092-8674(91)90362-3","volume":"67","author":"A Strasser","year":"1991","unstructured":"Strasser A, Harris AW, Cory S . Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889\u2013899.","journal-title":"Cell"},{"key":"BFcdd2011133_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1084\/jem.189.11.1691","volume":"189","author":"N Motoyama","year":"1999","unstructured":"Motoyama N, Kimura T, Takahashi T, Watanabe T, Nakano T . bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. J Exp Med 1999; 189: 1691\u20131698.","journal-title":"J Exp Med"},{"key":"BFcdd2011133_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1534-5807(01)00083-1","volume":"1","author":"P Bouillet","year":"2001","unstructured":"Bouillet P, Cory S, Zhang L-C, Strasser A, Adams JM . Degenerative disorders caused by Bcl-2 deficiency are prevented by loss of its BH3-only antagonist Bim. Dev Cell 2001; 1: 645\u2013653.","journal-title":"Dev Cell"},{"key":"BFcdd2011133_CR26","doi-asserted-by":"publisher","first-page":"12424","DOI":"10.1073\/pnas.95.21.12424","volume":"95","author":"CG Print","year":"1998","unstructured":"Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N et al. Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci USA 1998; 95: 12424\u201312431.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2011133_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.cdd.4400835","volume":"8","author":"LA O\u2019Reilly","year":"2001","unstructured":"O\u2019Reilly LA, Print C, Hausmann G, Moriishi K, Cory S, Huang DCS et al. Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. Cell Death Differ 2001; 8: 486\u2013494.","journal-title":"Cell Death Differ"},{"key":"BFcdd2011133_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nature02067","volume":"426","author":"JT Opferman","year":"2003","unstructured":"Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ . Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003; 426: 671\u2013676.","journal-title":"Nature"},{"key":"BFcdd2011133_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1126\/science.1106114","volume":"307","author":"J Opferman","year":"2005","unstructured":"Opferman J, Iwasaki H, Ong CC, Suh H, Mizuno S, Akashi K et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005; 307: 1101\u20131104.","journal-title":"Science"},{"key":"BFcdd2011133_CR30","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet P, Metcalf D, Huang DCS, Tarlinton DM, Kay TWH, K\u00f6ntgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735\u20131738.","journal-title":"Science"},{"key":"BFcdd2011133_CR31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1090072","volume":"302","author":"A Villunger","year":"2003","unstructured":"Villunger A, Michalak EM, Coultas L, M\u00fcllauer F, B\u00f6ck G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 2003; 302: 1036\u20131038.","journal-title":"Science"},{"key":"BFcdd2011133_CR32","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1172\/JCI35437","volume":"118","author":"MS Cragg","year":"2008","unstructured":"Cragg MS, Jansen ES, Cook M, Strasser A, Scott CL . Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic. J Clin Invest 2008; 118: 3651\u20133659.","journal-title":"J Clin Invest"},{"key":"BFcdd2011133_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.20041924","volume":"201","author":"M Mandal","year":"2005","unstructured":"Mandal M, Borowski C, Palomero T, Ferrando AA, Oberdoerffer P, Meng F et al. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med 2005; 201: 603\u2013614.","journal-title":"J Exp Med"},{"key":"BFcdd2011133_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cell.2007.03.017","volume":"129","author":"T Kaufmann","year":"2007","unstructured":"Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK et al. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 2007; 129: 423\u2013433.","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1038\/s41418-026-01826-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000}}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cdd2011133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cdd2011133","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cdd2011133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:04:02Z","timestamp":1786615442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2011133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,14]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFcdd2011133"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2011.133","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,14]]},"assertion":[{"value":"25 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41418-026-01826-2","URL":"https:\/\/doi.org\/10.1038\/s41418-026-01826-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}